NCT05085782View on ClinicalTrials.gov

Reconsolidation Therapy With Propranolol as a Treatment for Chronic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

August 31, 2025

Conditions
Chronic Low-back PainFibromyalgia
Interventions
DRUG

Propranolol Hydrochloride

6 weekly doses (40 to 80 mg) 1h before the reactivation procedure

DRUG

Placebo

6 weekly doses (40 to 80 mg) 1h before the reactivation procedure

BEHAVIORAL

Reactivation procedure

Description/visualization of painful movements/activities

BEHAVIORAL

Pain neuroscience education

In the form of 10 videos that participants will watch on their own time

Trial Locations (2)

J1H 4C4

Centre de recherche sur le vieillissement (CdRV), Sherbrooke

J1H5N4

CRCHUS: Centre de recherche du centre hospitalier universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
lead

Université de Sherbrooke

OTHER